graph TD
    "CDC" -- "recommends" --> "twodose series"
    "CDC" -- "recommends" --> "vaccination"
    "recombinant zoster vaccine RZV" -- "prevents" --> "herpes zoster"
    "recombinant zoster vaccine RZV" -- "effective in" --> "older adults"
    "recombinant zoster vaccine RZV" -- "effective regardless of" --> "immunocompromised status"
    "recombinant zoster vaccine RZV" -- "measures" --> "vaccine effectiveness VE"
    "twodose series" -- "increases" --> "vaccine effectiveness VE"
    "vaccine effectiveness VE" -- "protects against" --> "postherpetic neuralgia"
    "vaccine effectiveness VE" -- "protects against" --> "ophthalmicus"
    "Nadja A Vielot PhD" -- "is a" --> "epidemiologist"
    "Nadja A Vielot PhD" -- "affiliated with" --> "Department of Family Medicine"
    "Department of Family Medicine" -- "part of" --> "University of North Carolina School of Medicine"
    "University of North Carolina School of Medicine" -- "located in" --> "Chapel Hill North Carolina"
    "Nadja A Vielot PhD" -- "published in" --> "Annals of Internal Medicine"
    "Nadja A Vielot PhD" -- "studied" --> "vaccine effectiveness VE"
    "Nadja A Vielot PhD" -- "addresses hesitancy due to" --> "adverse events"
    "Annals of Internal Medicine" -- "published study on" --> "recombinant zoster vaccine RZV"
    "Medicare feeforservice" -- "source of data for" --> "data analysis"
    "data analysis" -- "measures" --> "vaccine effectiveness VE"
    "data analysis" -- "compares" --> "onedose vs twodose"
    "sensitivity analysis" -- "validates" --> "vaccine effectiveness VE"
    "recombinant zoster vaccine RZV" -- "compared to in subgroup analysis" --> "live zoster vaccine"
    "age groups" -- "similar across" --> "vaccine effectiveness VE"
    "Black individuals" -- "lower in" --> "vaccine effectiveness VE"
    "nonBlack individuals" -- "higher in" --> "vaccine effectiveness VE"
    "Hispanic individuals" -- "imprecise estimates for" --> "vaccine effectiveness VE"
    "immunocompromised status" -- "similar to immunocompetent" --> "vaccine effectiveness VE"
    "private insurance claim" -- "future source for" --> "data analysis"
    "vaccine uptake" -- "low for" --> "twodose series"
    "clinical outcomes" -- "includes" --> "herpes zoster"
    "clinical outcomes" -- "includes" --> "postherpetic neuralgia"
    "clinical outcomes" -- "includes" --> "ophthalmicus"